市場調查報告書

病毒載體、質體DNA製造市場:各產品類型,用途 - 產業洞察,預測,市場機會 2018年∼2026年

Viral Vectors and Plasmid DNA Manufacturing Market, By Product Type, Application - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2018-2026

出版商 Coherent Market Insights 商品編碼 798078
出版日期 內容資訊 英文 169 Pages
商品交期: 2-3個工作天內
價格
病毒載體、質體DNA製造市場:各產品類型,用途 - 產業洞察,預測,市場機會 2018年∼2026年 Viral Vectors and Plasmid DNA Manufacturing Market, By Product Type, Application - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2018-2026
出版日期: 2019年02月14日內容資訊: 英文 169 Pages
簡介

病毒載體及質體DNA,用於癌症、遺傳性疾病、病毒感染疾病等疾病的診斷和治療。治療用DNA透過媒介的幫助注入宿主。腺結合病毒為基礎的媒介因加入人類基因圖譜的同部位,比其他的病毒載體安全,廣泛用於阿茲海默症之類的疾病等。

本報告提供病毒載體、質體DNA製造市場調查,市場概要,各產品類型、用途、地區的市場規模的變化與預測,市場成長要素及阻礙因素分析,競爭情形,主要企業的簡介等全面性資訊。

目錄

第1章 調查目的與前提條件

  • 調查目的
  • 前提條件
  • 簡稱

第2章 市場範圍

  • 報告的說明
    • 市場定義和範圍
  • 摘要整理
    • 市場片段:各產品類型
    • 市場片段:各用途
    • 市場片段:各地區
  • Coherent Opportunity Map(COM)

第3章 市場動態,法規,趨勢分析

  • 市場動態
    • 成長要素
    • 阻礙因素
    • 市場機會
  • 影響分析
  • 開發平台分析
  • 面臨的課題:各稀少疾病的藥物研發計劃
  • 償付方案
  • 流行病學
  • PEST分析
  • 法規方案
  • 病毒比較分析
  • 合作與協定
  • 新產品的銷售
  • 投資機會
  • 產品開發與應用途徑的策略
  • 品牌分析
  • 歐洲的細胞療法及遺傳基因療法的製造設施

第4章 全球病毒載體、質體DNA製造市場:各產品類型

  • 簡介
  • 病毒載體
  • 質體DNA
  • 非病毒載體

第5章 全球病毒載體、質體DNA製造市場:各用途

  • 簡介
  • 癌症
  • 遺傳性疾病
  • 病毒感染
  • 其他

第6章 全球病毒載體、質體DNA製造市場:各地區

  • 簡介
  • 北美
  • 南美
  • 歐洲
  • 亞太地區
  • 中東
  • 非洲

第7章 競爭環境

  • 熱圖分析
  • 企業簡介
    • Kaneka Eurogentec S.A.
    • FinVector
    • Brammer Bio
    • Cell and Gene Therapy Catapult
    • Transgene SA
    • FUJIFILM Diosynth Biotechnologies
    • Sanofi
    • Spark Therapeutics
    • Cobra Biologics
    • uniQure
    • MassBiologics
    • 4D Molecular Therapeutics
    • Renova Therapeutics
    • Shenzhen SiBiono GeneTech Co., Ltd.
    • Thermo Fisher Scientific, Inc.
  • 分析師的見解

第8章 Section

  • 參考文獻
  • 調查方法
  • 關於Coherent Market Insights
目錄

Report Description

Viral vector and plasmid DNA is product of gene therapy, which is used in diagnosis and treatment of diseases such as cancer, inherited diseases, viral infections, and others. The therapeutic DNA is introduced in host with the help of a vector. Adeno associated virus based vector are much safer as compared with others viral vectors due to its integration at same site in human genome, and has wide application in various disorders such as Alzheimer's disease.

Market Dynamics

Increasing prevalence of cancer is a major factor driving growth of the viral vector and plasmid DNA manufacturing market. According to World Cancer Research Funds and the American Institute for Cancer Research, in 2018, there were around 18 million cases of cancer, of which around 9.5 million were in men and around 8.5 million in women, globally. Moreover, government and other organizations' initiatives regarding awareness of gene is expected to boost growth of the market. For instance, in June 2018 Alliance for Regenerative Medicine launched ARM Foundation for Cell and Gene Medicine to educate, empower, and engage public about cell and gene medicine as a treatment option. The foundation will accelerate patient's access to safe and curative gene therapies.

However, safety and efficacy issues, stringent regulatory framework and risk of mutagenesis are expected to limit the adoption if gene therapy, thereby hindering the market growth. For instance, some viral vectors, such as gamma-retroviruses, insert its genomes at random location on the host chromosomes, which can lead to cancer.

Key features of the study:

  • This report provides in-depth analysis of the viral vector and plasmid DNA manufacturing market and provides market size (US$ million) and Compound Annual Growth Rate (CAGR %) for the forecast period (2018 - 2026), considering 2017 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by key players
  • It profiles key players in the global viral vector and plasmid DNA manufacturing market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include, Kaneka Eurogentec S.A., FinVector, Brammer Bio, Cell and Gene Therapy Catapult, Transgene SA, FUJIFILM Diosynth Biotechnologies, Sanofi, Spark Therapeutics, Cobra Biologics, uniQure MassBiologics, 4D Molecular Therapeutics, Renova Therapeutics, Shenzhen SiBiono GeneTech Co., Ltd., and Thermo Fisher Scientific, Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
  • The global viral vector and plasmid DNA manufacturing market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the viral vector and plasmid DNA manufacturing market

Detailed Segmentation:

  • Global Viral Vector and Plasmid DNA Manufacturing Market, By Product Type:
    • Viral Vector
      • Retroviral
      • Adenoviral
      • Lentiviral
      • Adeno Associated
      • Others
    • Plasmid DNA
    • Nonviral Vector
  • Global Viral Vector and Plasmid DNA Manufacturing Market, By Application:
    • Cancer
    • Inherited Disorder
    • Viral Infection
    • Others
  • Global Viral Vector and Plasmid DNA Manufacturing Market, By Geography:
    • North America
      • By Product Type:
      • Viral Vector
      • Retroviral
      • Adenoviral
      • Lentiviral
      • Adeno Associated
      • Others
      • Plasmid DNA
      • Nonviral Vector
      • By Application:
      • Cancer
      • Inherited Disorder
      • Viral Infection
      • Others
      • By Country:
      • U.S.
      • Canada
    • Latin America
      • By Product Type:
      • Viral Vector
      • Retroviral
      • Adenoviral
      • Lentiviral
      • Adeno Associated
      • Others
      • Plasmid DNA
      • Nonviral Vector
      • By Application:
      • Cancer
      • Inherited Disorder
      • Viral Infection
      • Others
      • By Country:
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
    • Europe
      • By Product Type:
      • Viral Vector
      • Retroviral
      • Adenoviral
      • Lentiviral
      • Adeno Associated
      • Others
      • Plasmid DNA
      • Nonviral Vector
      • By Application:
      • Cancer
      • Inherited Disorder
      • Viral Infection
      • Others
      • By Country:
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
      • Russia
      • Rest of Europe
    • Asia Pacific
      • By Product Type:
      • Viral Vector
      • Retroviral
      • Adenoviral
      • Lentiviral
      • Adeno Associated
      • Others
      • Plasmid DNA
      • Nonviral Vector
      • By Application:
      • Cancer
      • Inherited Disorder
      • Viral Infection
      • Others
      • By Country:
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
    • Middle East
      • By Product Type:
      • Viral Vector
      • Retroviral
      • Adenoviral
      • Lentiviral
      • Adeno Associated
      • Others
      • Plasmid DNA
      • Nonviral Vector
      • By Application:
      • Cancer
      • Inherited Disorder
      • Viral Infection
      • Others
      • By Country:
      • GCC
      • Israel
      • Rest of Middle East
    • Africa
      • By Product Type:
      • Viral Vector
      • Retroviral
      • Adenoviral
      • Lentiviral
      • Adeno Associated
      • Others
      • Plasmid DNA
      • Nonviral Vector
      • By Application:
      • Cancer
      • Inherited Disorder
      • Viral Infection
      • Others
      • By Country:
      • South Africa
      • Central Africa
      • North Africa
  • Company Profiles
    • Kaneka Eurogentec S.A.*
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Key Highlights
      • Market Strategies
    • FinVector
    • Brammer Bio
    • Cell and Gene Therapy Catapult
    • Transgene SA
    • FUJIFILM Diosynth Biotechnologies
    • Sanofi
    • Spark Therapeutics
    • Cobra Biologics
    • uniQure
    • MassBiologics
    • 4D Molecular Therapeutics
    • Renova Therapeutics
    • Shenzhen SiBiono GeneTech Co., Ltd.
    • Thermo Fisher Scientific, Inc.

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Product Type
    • Market Snippet, By Application
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Pipeline Analysis
  • Challenges Faced By Rare Disease Drug Discovery Programs
  • Reimbursement Scenario
  • Epidemiology
  • Pest Analysis
  • Regulatory Scenario
  • Comparative Analysis Of Different Types Of Viral Systems
  • Collaborations And Agreements
  • New Product Launches
  • Investment Opportunities
  • Strategies For Product Development And Application Pathways
  • Brand Analysis
  • Cell & Gene Therapy Manufacturing Capacities In Europe

4. Global Viral Vector and Plasmid DNA Manufacturing Market, By Product Type, 2018 - 2026, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2018 and 2026 (%)
    • Y-o-Y Growth Analysis, 2017 - 2026
    • Segment Trends
  • Viral Vector
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
    • Retroviral
    • Adenoviral
    • Lentiviral
    • Adeno Associated
    • Others
  • Plasmid DNA
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
  • Nonviral Vector
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)

5. Global Viral Vector and Plasmid DNA Manufacturing Market, By Application, 2018 - 2026, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2018 and 2026 (%)
    • Y-o-Y Growth Analysis, 2017 - 2026
    • Segment Trends
  • Cancer
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
  • Inherited Disorder
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
  • Viral Infection
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)

6. Global Viral Vector and Plasmid DNA Manufacturing Market, By Region, 2018 - 2026, (US$ Mn)

  • Introduction
    • Market Share Analysis, By Region, 2018 and 2026 (%)
    • Y-o-Y Growth Analysis, For Regions, 2017-2026
  • North America
    • Market Size and Forecast, By Product Type, 2016 - 2026, (US$ Mn)
    • Market Size and Forecast, By Application, 2016 - 2026, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Mn)
    • U.S.
    • Canada
  • Latin America
    • Market Size and Forecast, By Product Type, 2016 - 2026, (US$ Mn)
    • Market Size and Forecast, By Application, 2016 - 2026, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Mn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Europe
    • Market Size and Forecast, By Product Type, 2016 - 2026, (US$ Mn)
    • Market Size and Forecast, By Application, 2016 - 2026, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Mn)
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, By Product Type, 2016 - 2026, (US$ Mn)
    • Market Size and Forecast, By Application, 2016 - 2026, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Mn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of APAC
  • Middle East
    • Market Size and Forecast, By Product Type, 2016 - 2026, (US$ Mn)
    • Market Size and Forecast, By Application, 2016 - 2026, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Mn)
    • GCC
    • Israel
    • Rest of Middle East
  • Africa
    • Market Size and Forecast, By Product Type, 2016 - 2026, (US$ Mn)
    • Market Size and Forecast, By Application, 2016 - 2026, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Mn)
    • South Africa
    • Central Africa
    • North Africa

7. Competitive Landscape

  • Heat Map Analysis
  • Company Profiles
    • Kaneka Eurogentec S.A.
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • FinVector
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Brammer Bio
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Cell and Gene Therapy Catapult
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Transgene SA
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • FUJIFILM Diosynth Biotechnologies
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Sanofi
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Spark Therapeutics
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Cobra Biologics
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • uniQure
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • MassBiologics
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • 4D Molecular Therapeutics
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Renova Therapeutics
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Shenzhen SiBiono GeneTech Co., Ltd.
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Thermo Fisher Scientific, Inc.
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
  • Analyst Views

8. Section

  • References
  • Research Methodology
  • About us and Sales Contact